Plans for nanny-state ban on prime-time alcohol ads binned by Wes Streeting
The Sun understands Wes Streeting has now rejected calls to outlaw advertising booze between 5.30pm and 9pm.
The ban would have included ads such as David Beckham' s for Stella Artois.
The crackdown was set to be part of Mr Streeting's landmark 10 Year Plan for the NHS, which will be unveiled on Thursday.
A source confirmed the ad-ban won't feature but there will be new proposals for tackling problem drinking.
Responding to news that ads will stay, an industry source said: 'Sports supporters, clubs and boozers will all raise a glass to this decision, whether they watch games on the terraces or on TV.
'It keeps a vital source of money flowing into sport from top to bottom.'
Shadow Business Secretary Andrew Griffith had previously said of the plans: 'This is nothing but nanny statism from an incompetent Labour government waging war on pubs.
'This would be the final nail in the coffin for many.'
Junk food ads are to be banned between 5.30pm and 9pm from October.
1
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
30 minutes ago
- Daily Mail
Treasury faces £1bn blow from AstraZeneca exit as pharma giant's boss mulls New York move
AstraZeneca could blow a £1billion hole in the Treasury's coffers if it abandons the UK for the US stock market. The drug giant is estimated to bring in around £300million in stamp duty every year as well as hundreds of millions in tax from the £3.2billion in dividend payments annually, according to analysts at Peel Hunt. If it moves its headquarters overseas, as boss Pascal Soriot is thought to be considering, its British workforce is expected to shrink, depriving the Government of payroll taxes and corporation tax on profits, which last year stood at £6.4billion. The warnings came after reports said Soriot, who has led Astra since 2012, is thinking about shifting the £161billion firm's stock market listing from London to Wall Street due to frustration about UK rules on medicine approvals and drug prices. It has fuelled criticism of the Government's plan to boost economic growth, with life sciences previously cited as a core part of its industrial strategy. 'The fact that our single largest company is contemplating leaving shows the Government's economic plan is in chaos,' said Conservative business spokesman Andrew Griffith. 'Businesses rightly sense this Government does not value wealth creators, and after 12 whole months they still haven't published a strategy for the critical life sciences sector.' It also sparked alarm among City figures who believe the pharma giant's departure could spark a rush to the exit for other major London-listed businesses, leaving the UK as an economic backwater. 'It's death by a thousand cuts here. There's been this trend of UK companies getting large and then wanting to move their listing,' said April LaRusse, who is the head of investment specialists at Insight Investment. 'They can get access to much deeper capital markets, their share price tends to trade at a higher level if it's listed in the US – so there are reasons they want to do this.' She added that about 700 companies had moved their listing to the US from the UK since 2015. 'You can understand why AstraZeneca might be thinking about this,' she said. Soriot, 66, has criticised the UK and Europe for falling behind countries such as the US and China in developing medicines. Astra is also one of several global pharma giants locked in a bitter row with the Government over a drug pricing scheme which requires them to repay at least 23 per cent of the money they make from medicine sales back to the NHS. The industry has lobbied intensely for the rate to be reduced, warning it risks hitting funding to develop new drugs.
Daily Mail
30 minutes ago
- Daily Mail
High St set for more branch closures as Santander snaps up rival TSB in £2.9bn deal
Santander yesterday admitted that branches could be closed and jobs lost as it takes over rival TSB. The Spanish bank, led by Ana Botin, also hinted that the TSB brand could disappear from the High Street, though no decisions have yet been made. The comments came a day after TSB's Spanish owner Sabadell agreed to sell the lender to Santander in a deal worth up to £2.9billion. It is expected to complete at the start of next year. TSB employs 5,000 people operating out of 175 branches while Santander UK has 349 branches with 18,000 staff. Asked about closures and job losses, Santander's UK boss Mike Regnier said: 'There will be efficiencies that we expect to make.' Santander expects to shave 13 per cent off the combined costs of Santander UK and TSB as a result of the takeover. Regnier said that will 'come from a number of areas', which will include bringing two IT platforms into one as well as back office functions. Speaking to the BBC, he added: 'All of us have been reducing and trimming the size of our branch networks. 'There's no point having two branches in the same town serving the same customers so there will be opportunities. When we complete the integration – and that won't happen for a few years – at that point we'll take a look and make decisions then.' The comments are likely to alarm campaigners who say the closure of huge numbers of bank branches over recent years – as many customers shun them in favour of online banking – has left the vulnerable and elderly in limbo. TSB had more than 600 branches when the brand was revived and spun out of Lloyds Banking Group in 2014. It was bought for £1.7billion by Sabadell and since then has shrunk dramatically. Figures from consumer group Which? show TSB has shut 459 branches since 2015 while Santander has axed 493. The deal came despite persistent speculation this year that Santander planned to leave the UK. But Regnier yesterday reiterated its commitment to Britain, saying it had 'invested an awful lot in the UK' and the deal was a 'vote of confidence'. He said that the takeover would help accelerate its growth plan and 'create one of the strongest, most competitive banks in the UK'. Regnier said TSB was a powerful brand but that 'typically at Santander we tend to use the Santander brand on the High Street around the world. That's the approach we normally take.' Jenny Ross, Which? Money editor, said the deal 'could understandably be concerning for some TSB and Santander customers, particularly those who prefer to use a local branch for their banking'. She added: 'If this deal goes ahead, the Financial Conduct Authority must look closely at any planned branch closures to ensure that there is no risk of customers, especially those with disabilities, losing access to local banking services or cash.' Tax raid warning Santander UK boss Mike Regnier has sounded the alarm over higher banking taxes as Rachel Reeves tries to fill the black hole in public finances. He said: 'Something the sector has made clear to this Government and previous governments is the importance of a strong banking sector in supporting economic growth. We lend into the economy. Santander lends £7,500 for every person in the UK. That is what the economy needs to grow and if you don't have a strong banking sector you won't get that support and that lending. 'Putting taxes up etc: these are not things that support a future growing economy because you won't have as strong a banking sector.'
Daily Mail
30 minutes ago
- Daily Mail
Private equity giant KKR wins takeover battle for British scientific testing kit maker Spectris
Private equity giant KKR has trumped Advent with a £4.7billion takeover bid for Spectris. In another blow to the City, the British scientific testing kit maker is the latest firm to leave the London stock market. It came as research from broker Peel Hunt showed the UK is on course for the biggest year of takeovers since 2021, after £74billion of offers so far this year. The Spectris board withdrew support for the £4.4billion Advent bid in favour of KKR. New York buyout group KKR was dubbed the 'barbarians at the gate' for its fearsome reputation following a 1989 takeover of RJR Nabisco, which was turned into a book and film. Spectris chairman Mark Williamson said: 'KKR's offer provides attractive and immediate cash value for shareholders and a compelling vision for the future of the group the board believes will be to the benefit of stakeholders.' It comes amid a flurry of takeovers on London's stock market. Last month, KKR lost out when the GP surgery owner Assura accepted a £1.8billion offer from Primary Health Properties. Microchip designer Alphawave agreed a £1.8billion takeover by US software giant and Nvidia rival Qualcomm. And in the last few months, ready meal maker Greencore bought food manufacturer Bakkavor for £1.2billion and Dowlais, the car parts arm of GKN, was snapped up for £1.1billion by American Axle and Manufacturing.
